U.S. Markets open in 9 hrs 11 mins

Clearside Biomedical, Inc. (CLSD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.38+0.84 (+18.50%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • Is Clearside Stock a Buy Right Now? This Is What You Need to Know
    TipRanks

    Is Clearside Stock a Buy Right Now? This Is What You Need to Know

    The combination of small cap biotech and upcoming clinical trial results is a potent one for investors, although it is fraught with risk. Should the outcome miss the target, the shares will be offloaded faster than you can say phase 1. However, deliver the goods and the rewards are plentiful. Investors of Clearside Biomedical (CLSD) were sitting on the right side of this equation on Tuesday. Shares of the eye disease-focused company took off by 38% after the company announced positive clinical r

  • Why Clearside Biomedical Stock Surged Today
    Motley Fool

    Why Clearside Biomedical Stock Surged Today

    As of 3 p.m. EDT, the biopharmaceutical company's stock price was up more than 12% after rising as much as 47% earlier in the day. Clearside Biomedical is developing an experimental treatment for wet age-related macular degeneration (AMD). Investors bid up eye care specialist Clearside Biomedical's shares on Thursday.

  • TheStreet.com

    Clearside Jumps; Wedbush Triples Target After Eye-Drug Trial Progress

    Wedbush raised its price target on Clearside after the company reported progress in a clinical trial of CLS-AX, which treats age-related macular degeneration.